Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.
The FDA has recommended providers not administer any products from Main Street until further guidance is provided.
More Articles on Compounding Pharmacy Contamination:
FDA Warns Drugs From Florida Compounding Shop May Be Contaminated
New Sterile Compounding Guidelines Released